Biocartis Group NV BCART-BE:Euronext Brussels

*Data is delayed | EUR
Last | 02/24/21 CET
4.57UNCH (UNCH)
52 week range
2.75 - 5.92

...

Loading . . .

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close4.57
  • 52 Week High5.92
  • 52 Week High Date04/24/20
  • 52 Week Low2.75
  • 52 Week Low Date03/17/20
  • Market Cap306.85M
  • Shares Out56.38M
  • 10 Day Average Volume79,618
  • Dividend-
  • Dividend Yield-
  • Beta1.42
  • 1 Year % Change-16.39

RATIOS/PROFITABILITY

  • EPS (TTM)-1.17
  • P/E (TTM)-3.89
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Biocartis Group NV News

There is no recent news for this security.

Latest BCART-BE News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Biocartis Group NV is a Belgium-based company, which specializes in the development of molecular diagnostic systems, especially for the treatment of cancers and infectious diseases, the products ensure the analysis of biomolecules associated with risk factors, early detection, treatment selection and monitoring of disease. The group has the Idylla system to deliver results within a period of between 35 to 150 minutes.
Christian Reinaudo
Chairman
Herman Verrelst
Chief Executive Officer
Piet Houwen
Chief Operating Officer
Benoit Devogelaere
Chief Technology Officer
Address
Generaal de Wittelaan 11B
Malines (mechelen)
2800
Belgium